GLP-1 weight-loss gummies, patches and drops – miracle alternatives or snake oil?
Source · Johannesburg Sunday World
TLDR
Experts quoted by Johannesburg Sunday World warn that gummies, patches and drops marketed as GLP-1 alternatives lack evidence of effects comparable to prescription medicines. The article also reports that South African regulators intensified enforcement against unlawful manufacture and distribution of unregistered semaglutide and tirzepatide medicines in May 2026.
- 01Obiflex CEO Sean Barnes says GLP-1 patches, gummies and drops are not registered for their advertised claims in South Africa.
- 02Dr Gerhard Vosloo says modest changes in natural GLP-1 release from some ingredients differ from sustained prescription-medicine effects; ordinary patches have not demonstrated comparable therapeutic effects.
- 03SAHPRA and the South African Pharmacy Council raised concerns about inadequate testing and manufacturing conditions involving unregistered GLP-1 and GIP medicines.
Why it matters Editorial
The report highlights evidence and regulatory distinctions between prescription peptide medicines and products marketed as alternatives.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
Caribbean National Weekly
Generics and Biosimilars Initiative